New Big Data Study From MIT Puts Clinical Trial Success Rate at 14 Percent

Drug Industry Daily
A A
Nearly 14 percent of all drugs in clinical trials eventually win approval from the FDA — a much higher percentage than previously thought, according to a new study from the MIT Sloan School of Management.

To View This Article:

Login

Subscribe To Drug Industry Daily